checkAd

     149  0 Kommentare RedHill Announces Additional Insider Buying - Seite 2

    Company contact:
    Adi Frish
    Chief Corporate & Business Development Officer
    RedHill Biopharma
    +972-54-6543-112
    adi@redhillbio.com

    Media contacts:
    U.S.: Bryan Gibbs, Finn Partners
    +1 212 529 2236
    bryan.gibbs@finnpartners.com
    UK: Amber Fennell, Consilium
    +44 (0) 7739 658 783
    fennell@consilium-comms.com

    [1] Full prescribing information for Movantik ® (naloxegol) is available at: www.Movantik.com .

    [2] Full prescribing information for Talicia ® (omeprazole magnesium, amoxicillin and rifabutin) is available at: www.Talicia.com .

    [3] Full prescribing information for Aemcolo ® (rifamycin) is available at: www.Aemcolo.com .

    This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com .

    SOURCE: RedHill Biopharma Ltd



    View source version on accesswire.com:
    https://www.accesswire.com/677788/RedHill-Announces-Additional-Insider ...

    Seite 2 von 2


    Diskutieren Sie über die enthaltenen Werte


    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    RedHill Announces Additional Insider Buying - Seite 2 RALEIGH, NC and TEL-AVIV, ISRAEL / ACCESSWIRE / December 15, 2021 / RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that members of its board of directors and senior …